BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 132 filers reported holding BRIDGEBIO PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $4,919,000 | -63.3% | 294,879 | +3.1% | 0.31% | -68.2% |
| Q3 2021 | $13,411,000 | -51.3% | 286,132 | -36.7% | 0.98% | -43.3% |
| Q2 2021 | $27,553,000 | -8.6% | 451,982 | -7.7% | 1.73% | -17.8% |
| Q1 2021 | $30,161,000 | +3.0% | 489,623 | +18.9% | 2.10% | -7.1% |
| Q4 2020 | $29,281,000 | +166.4% | 411,771 | +40.5% | 2.26% | +90.4% |
| Q3 2020 | $10,993,000 | +531.8% | 292,982 | +449.1% | 1.19% | +236.5% |
| Q2 2020 | $1,740,000 | -0.7% | 53,356 | -11.7% | 0.35% | +3.5% |
| Q1 2020 | $1,752,000 | +152.4% | 60,424 | +205.0% | 0.34% | +380.3% |
| Q4 2019 | $694,000 | +216.9% | 19,809 | +94.5% | 0.07% | +294.4% |
| Q3 2019 | $219,000 | – | 10,185 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 6,068,125 | $55,099,000 | 39.31% |
| M28 Capital Management LP | 466,200 | $4,233,000 | 4.74% |
| Kohlberg Kravis Roberts & Co. L.P. | 31,060,971 | $282,034,000 | 3.75% |
| Octagon Capital Advisors LP | 933,743 | $8,478,000 | 2.26% |
| VIKING GLOBAL INVESTORS LP | 26,620,991 | $241,719,000 | 1.11% |
| HHLR ADVISORS, LTD. | 5,362,014 | $48,687,000 | 1.04% |
| Cormorant Asset Management, LP | 1,469,179 | $13,340,000 | 1.01% |
| Knott David M Jr | 213,206 | $1,936,000 | 0.81% |
| Fernwood Investment Management, LLC | 183,900 | $1,670,000 | 0.72% |
| HighVista Strategies LLC | 105,942 | $962,000 | 0.58% |